Discontinuation report TRANSDERM-NITRO 0.4
| Report ID | 119964 |
| Drug Identification Number | 00852384 |
| Brand name | TRANSDERM-NITRO 0.4 |
| Common or Proper name | Transderm Nitro 0.4 |
| Company Name | NOVARTIS PHARMACEUTICALS CANADA INC |
| Market Status | CANCELLED POST MARKET |
| Active Ingredient(s) | NITROGLYCERIN |
| Strength(s) | 0.4MG |
| Dosage form(s) | PATCH (EXTENDED RELEASE) |
| Route of administration | TRANSDERMAL TRANSDERMAL |
| Packaging size | 30 |
| ATC code | C01DA |
| ATC description | VASODILATORS USED IN CARDIAC DISEASES |
| Reason for discontinuation | Business reasons |
| Anticipated discontinuation date | 2020-10-31 |
| Actual discontinuation date | 2020-10-31 |
| Remaining supply date | 2020-10-31 |
| Discontinuation status | Discontinued |
| Discontinuation decision reversal | No |
| Information on remaining supply | |
| Company comments | The 0,6 mg will still be available until stock depletion or shelf life expiration (Aug 2021 |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 700 RUE SAINT-HUBERT MONTREAL, QUEBEC CANADA H2Y 0C1 |
| Company contact information | [email protected] |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v4 | 2020-12-21 | French | Compare |
| v3 | 2020-12-21 | English | Compare |
| v2 | 2020-07-10 | French | Compare |
| v1 | 2020-07-10 | English | Compare |
Showing 1 to 4 of 4